C3.ai, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AI research report →
Range $6 – $12
Price Chart
About the company
C3. ai, Inc. is a leading provider of enterprise artificial intelligence (AI) software solutions, serving a global clientele across North America, Europe, the Middle East, Africa, and the Asia Pacific region.
- CEO
- Thomas Siebel
- IPO
- 2020
- Employees
- 764
- HQ
- Redwood City, CA, US
Get TickerSpark's AI analysis on AI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.56B
- P/E
- -3.09
- Fwd P/E
- 25.74
- PEG
- 0.08
- P/S
- 6.28
- P/B
- 2.31
- EV/EBITDA
- -3.29
- Div Yield
- 0.00%
- Gross Margin
- 30.92%
- Op Margin
- -194.86%
- Net Margin
- -187.95%
- ROE
- -63.91%
- ROIC
- -68.18%
Latest fiscal year · YoY change
- Revenue
- $250.27M-35.7%
- Gross Profit
- $77.38M-67.2%
- Op Income
- $-487,670,000
- Net Income
- $-470,369,000-62.9%
- EPS
- $-3.35-49.6%
- OCF Growth
- -355.9%
- FCF Growth
- -329.0%
- 52W High
- $20.22
- 52W Low
- $7.67
- 50D MA
- $9.54
- 200D MA
- $10.93
- Beta
- 2.07
- RSI (14)
- 60
- Avg Volume
- 6.23M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
C3.ai reported Q4 FY2026 revenue of $51.6 million but paired it with a sharply lower FY2027 outlook, while management framed the business as an aggressive turnaround centered on sales restructuring and cost cuts.· June 3, 2026
- Q4 revenue was $51.6 million, with 94% from subscriptions; non-GAAP EPS was a loss of $0.33 and gross margin was 37%.
- Management said the company cut headcount from roughly 1,075 to about 700 and has already realized almost $130 million of planned savings.
- FY2027 guidance calls for revenue of $210 million to $240 million and non-GAAP operating loss of $128 million to $160 million.
- Tom Siebel repeatedly said the core problem has been sales execution, not product quality or market size, and called the prior performance “completely unacceptable.”
- The company ended the quarter with $575.4 million in cash equivalents and marketable securities, later updated to $673 million after Tom Siebel’s share purchase was received.
Total revenue for Q4 FY2026 was $51.6 million. Subscription revenue was $48.4 million, or 94% of total revenue, and professional services revenue was $3.2 million, including $2.1 million of PES. Non-GAAP gross profit was $19.3 million and non-GAAP gross margin was 37%; professional services gross margin was 78%. Non-GAAP operating loss was $54.4 million, non-GAAP net loss was $48.8 million, and non-GAAP loss per share was $0.33. Free cash flow was $54.8 million, and the company ended the quarter with $575.4 million in cash equivalents and marketable securities, later noted as $673 million after the CEO’s stock purchase cash was received. For FY2027, management guided revenue to $210 million to $240 million and non-GAAP operating loss to $128 million to $160 million; Q1 FY2027 revenue guidance was $50 million to $54 million and non-GAAP operating loss guidance was $40.5 million to $48.5 million.
Tom Siebel said the company is in a turnaround and that virtually everything is being reworked: sales, products, services, leadership, and go-to-market. He emphasized a shift toward an “agentic AI-first mindset,” broader territory coverage, and focusing on larger enterprise accounts rather than a narrow set of deals. His tone was highly self-critical about prior execution and very confident that the new structure will improve customer success, revenue growth, and shareholder value.
Hitesh Lath highlighted that Q4 revenue was $51.6 million, gross margin was 37%, operating loss was $54.4 million, and free cash flow was $54.8 million. He said non-GAAP operating expenses fell to $106 million, down $33.9 million from $139.9 million in the same quarter last year, and reiterated that the restructuring is targeting about $135 million of annual cost savings; the company has already completed actions to realize almost $130 million of those savings. He also noted the company closed the quarter well-capitalized with $575.4 million in cash equivalents and marketable securities, later updated to $673 million after the CEO’s stock purchase funds were received.
Analysts focused on why revenue fell so sharply versus FY2025, whether churn and non-renewals had worsened, and how federal contract ramps and the mix of software versus services/PES should be modeled. Siebel attributed the revenue decline primarily to weak sales execution and said he did not think there had been a significant loss of production customers; Lath supported that by saying the company has not experienced a significant loss of production customers. On guidance mix, management said it guides to total revenue and could not reliably break out the mix of demo licenses, PES, and services after the restructuring, while reiterating that the company is focused on software revenue.
Management argued the market opportunity is large and still expanding, citing a roughly $10 billion enterprise AI market in 2026 growing at 50% CAGR, and said customers can still find budget for AI initiatives. The company also emphasized a stronger balance sheet, major cost reductions, and a more focused sales model covering many more accounts with dedicated customer teams.
The quarter and guidance both reflect a severe slowdown from prior revenue levels, and management repeatedly acknowledged that sales execution has been “miserable” and “completely unacceptable.” The company also said it does not yet know how the new go-to-market mix will shake out, which makes the FY2027 revenue path and product/services mix less visible than usual.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 90.2%
- Shares Outstanding
- 151.95M
- Float Shares
- 136.99M
of shares held by institutions
349 13F filers
Buy/sell ratio 0.47. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for AI, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 14.47M | ▲ 108.01K |
| Blackrock, Inc. | 14.26M | ▲ 2.05M |
| Vanguard Capital Management LLC | 5.99M | ▲ 150.31K |
| Morgan Stanley | 5.03M | ▼ 699.86K |
| Bnp Paribas Arbitrage, Snc | 3.54M | ▲ 1.78M |
| State Street Corp | 3.49M | ▲ 337.74K |
| Geode Capital Management, LLC | 3.43M | ▲ 505.58K |
| Goldman Sachs Group Inc | 3.22M | ▼ 620.04K |
| Millennium Management LLC | 3.14M | ▲ 287.88K |
| Hrt Financial LP | 2.97M | ▲ 2.41M |
| Bank Of America Corp | 2.87M | ▼ 409.82K |
| Mirae Asset Global Etfs Holdings Ltd. | 2.39M | ▲ 32.95K |
Held by 324 ETFs
Biggest fund positions in AI by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 11, 26 | SIEBEL THOMAS M | other | 453,314 |
| Aug 11, 26 | SIEBEL THOMAS M | other | 453,314 |
| Aug 11, 26 | SIEBEL THOMAS M | sell | 453,314 |
| Aug 4, 26 | Lath Hitesh | sell | 20,000 |
| Aug 4, 26 | SIEBEL THOMAS M | other | 143,834 |
| Aug 2, 26 | SIEBEL THOMAS M | other | 283,334 |
| Aug 3, 26 | SIEBEL THOMAS M | sell | 139,500 |
| Aug 4, 26 | SIEBEL THOMAS M | other | 143,834 |
| Aug 2, 26 | SIEBEL THOMAS M | other | 283,334 |
| Jul 15, 26 | Hyten John E. | sell | 2,500 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AI coverage
Recent articles, reports, and earnings notes.

Power Analytics Global's De-SPAC: What Investors Need to Know
Power Analytics Global is a private AI, analytics, and quantum-resistant security company going public through a merger with Drugs Made In America Acquisition Corp. (DMAA). The deal is live, but the setup still hinges on redemptions, financing, and whether the company can validate the revenue contracts tied to its valuation.

Can You Actually Buy ElevenLabs Stock Right Now?
No, ElevenLabs is not publicly traded. Retail investors mostly have to wait for an IPO, look at comparable public AI names, or — if accredited — explore private secondary markets with no guarantee of access.

Scale AI in 2026: IPO Outlook + Backdoor Routes
No, Scale AI is not publicly traded. Retail investors can’t buy Scale AI stock directly today, so the realistic paths are waiting for an IPO, looking at public comps, or exploring accredited-only private secondary markets if shares are available.
Want a deeper read on AI?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
C3 AI to Announce Financial Results for Fiscal First Quarter 2027 on September 2, 2026
gurufocus.com · Aug 20
C3.ai vs. Seagate Technology: Which Technology Stock Is a Better Buy in 2026?
fool.com · Aug 19
New Experian Report Reveals AI Trust Gap as Consumers Embrace AI but Resist High-stakes Decisions
gurufocus.com · Aug 19
C3.ai vs. Lumentum: What Recent Revenue Trajectories Tell Investors About These Artificial Intelligence Companies
fool.com · Aug 19
Longevica Therapeutics Appoints Ex-Genentech Biotech Veteran Dr. Prasun Mishra as CEO to Advance World's Largest $13 Million Mammalian Longevity Study Toward Clinical Development
businesswire.com · Aug 18
C3.ai, Inc. (AI) Registers a Bigger Fall Than the Market: Important Facts to Note
zacks.com · Aug 17
C3.ai CEO Thomas Siebel Sells 453,000 Shares for $4.8 Million
fool.com · Aug 14
C3.ai Remains Turbulent: Why One Of Wall Street's Most Outspoken Pros Expects 50% Returns From Here
247wallst.com · Aug 14
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.